荃信生物-B(02509.HK)耗资1107万港元回购0.24%股份

Core Viewpoint - The company has repurchased a total of 549,800 ordinary shares as treasury stock, representing approximately 0.24% of the existing issued share capital as of the announcement date [1] Group 1 - The share repurchase was authorized by shareholders at the annual general meeting held on June 20, 2025 [1] - The total amount involved in the repurchase is approximately HKD 11.07 million, excluding commissions and other expenses [1] - The repurchase took place on the Hong Kong Stock Exchange from November 6, 2025, to the date of the announcement [1]